Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression?

1999 ◽  
Vol 21 (3) ◽  
pp. 158-167 ◽  
Author(s):  
Bradley N Gaynes ◽  
Kathryn M Magruder ◽  
Barbara J Burns ◽  
H.Ryan Wagner ◽  
Kimberly S.H Yarnall ◽  
...  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Jenny Nyberg ◽  
Malin Henriksson ◽  
Alexander Wall ◽  
Torbjörn Vestberg ◽  
Maria Westerlund ◽  
...  

Abstract Background Deficits in cognitive performance are reported in patients with anxiety disorders, but research is limited and inconsistent. We aimed to investigate cross-sectional associations between cognitive function, with focus on executive function, and anxiety severity in primary care patients diagnosed with anxiety disorders. Methods 189 Swedish patients aged 18–65 years (31% men) with anxiety disorders diagnosed according to Mini International Neuropsychiatric Interview were included. Severity of anxiety was assessed using Beck Anxiety Inventory self-assessment scale. Digit span, block design and matrix reasoning tests from the Wechsler Adult Intelligence Scale IV, and the design fluency test from the Delis-Kaplan Executive Function System were used. Multivariable linear regression models were applied to investigate the relationship of anxiety severity and cognitive functioning. Comparisons were also performed to a normed non-clinical population, using the Wilcoxon signed rank test. Results More severe anxiety was associated with lower digit span test scores (R2 = 0.109, B = -0.040, p = 0.018), but not with block design, matrix reasoning or design fluency tests scores, after adjustment for comorbid major depression in a multivariable model. When compared to a normed population, patients with anxiety performed significantly lower on the block design, digit span forward, digit span sequencing and matrix reasoning tests. Conclusions Severity of anxiety among patients with anxiety disorder was associated with executive functions related to working memory, independently of comorbid major depression, but not with lower fluid intelligence. A further understanding of the executive behavioral control in patients with anxiety could allow for more tailored treatment strategies including medication, therapy and interventions targeted to improve specific cognitive domains.


2015 ◽  
Vol 207 (3) ◽  
pp. 235-242 ◽  
Author(s):  
M. Belvederi Murri ◽  
M. Amore ◽  
M. Menchetti ◽  
G. Toni ◽  
F. Neviani ◽  
...  

BackgroundInterventions including physical exercise may help improve the outcomes of late-life major depression, but few studies are available.AimsTo investigate whether augmenting sertraline therapy with physical exercise leads to better outcomes of late-life major depression.MethodPrimary care patients (>65 years) with major depression were randomised to 24 weeks of higher-intensity, progressive aerobic exercise plus sertraline (S+PAE), lower-intensity, non-progressive exercise plus sertraline (S+NPE) and sertraline alone. The primary outcome was remission (a score of $10 on the Hamilton Rating Scale for Depression).ResultsA total of 121 patients were included. At study end, 45% of participants in the sertraline group, 73% of those in the S+NPE group and 81% of those in the S+PAE group achieved remission (P = 0.001). A shorter time to remission was observed in the S+PAE group than in the sertraline-only group.ConclusionsPhysical exercise may be a safe and effective augmentation to antidepressant therapy in late-life major depression.


2008 ◽  
Vol 17 (10) ◽  
pp. 1285-1294 ◽  
Author(s):  
Dennis A. Revicki ◽  
Nancy Brandenburg ◽  
Louis Matza ◽  
Mark C. Hornbrook ◽  
David Feeny

2006 ◽  
Vol 194 (2) ◽  
pp. 91-97 ◽  
Author(s):  
Benjamin F. Rodriguez ◽  
Risa B. Weisberg ◽  
Maria E. Pagano ◽  
Steven E. Bruce ◽  
Michael A. Spencer ◽  
...  

2006 ◽  
Vol 16 (3) ◽  
pp. 122-132 ◽  
Author(s):  
Kitty S. Chan ◽  
Chloe E. Bird ◽  
Robert Weiss ◽  
Naihua Duan ◽  
Lisa S. Meredith ◽  
...  

2005 ◽  
Vol 20 (3) ◽  
pp. 229-235 ◽  
Author(s):  
Marc Ansseau ◽  
Benjamin Fischler ◽  
Michel Dierick ◽  
Annick Mignon ◽  
Sophie Leyman

AbstractPurposeGADIS aims at determining the prevalence of generalized anxiety disorder (GAD) and major depression (MD) in primary care and their impact on the patient’s functioning in Belgium and Luxemburg.MethodsA large scale screening program was conducted at the consultation of general practitioners to detect patients with GAD and MD according to DSM-IV criteria. We collected additional data regarding the use of hypnotic, tranquilizer, antidepressant and analgesic medications. Impact on the patient was assessed with the Sheehan disability scale.ResultsThree hundred GP’s in Belgium and Luxemburg were asked to screen 50 consecutive patients. Of the 13,677 analyzed patients, 8.3% were diagnosed to have GAD and 6.3% MD. Comorbidity was observed in 4.2% of patients. The prevalence was much higher in the French-speaking part of Belgium. GAD and MD were associated with impairment in social, familial and professional functioning. Only a minority of patients with GAD and/or MD was treated with an antidepressant and almost half of subjects with GAD and/or MD were treated with a tranquilizer.ConclusionsPrevalence rates of GAD and MD in primary care in Belgium are comparable to other countries. GAD and MD are disabling conditions. Antidepressants are still used only in a minority of subjects with GAD and/or MD in primary care in Belgium and Luxemburg. The prevalence of GAD and MD appears to be much higher in French-speaking parts of Belgium.


Sign in / Sign up

Export Citation Format

Share Document